跳轉至內容
Merck

1.00419

SAFC

Parteck® M 200(甘露醇)

EMPROVE® ESSENTIAL, Ph. Eur., ChP, JP, USP, E 421

製藥生產

同義詞:

D-甘露醇

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C6H14O6
CAS號碼:
分子量::
182.17
MDL號碼:
分類程式碼代碼:
12352201
酶號碼:
E421
酶委員會索引編號:
200-711-8
暫時無法取得訂價和供貨情況

agency

BP
ChP
JP
Ph. Eur.
USP

品質等級

產品線

EMPROVE® ESSENTIAL

形狀

fine powder

自燃溫度

410 °C

品質

E 421

粒徑

(see specification)

bp

290-295 °C/4 hPa

mp

164-169 °C

溶解度

213 g/L

應用

liquid formulation
pharmaceutical
solid formulation

儲存溫度

2-25°C

SMILES 字串

OC(C(O)C(O)CO)C(O)CO

InChI

1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2

InChI 密鑰

FBPFZTCFMRRESA-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

一般說明

With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

應用

Parteck® M excipient achieves excellent compressibility while keeping the API stable throughout your manufacturing process and beyond. Based on directly compressible mannitol, it does not require further processing or high compression forces. The unique and large surface area of Parteck® M excipient enables rapid disintegration and quick release regardless of the dosage. It is well suitable for tableting processesusing direct compression or granulation techniques such as wet granulation androller compaction. Parteck® M is available in different particle sizes.
The specification of the product is part of the Emprove® Material Qualification Dossier and can be found under "General Properties".

特點和優勢

  • High compactibility at low compression forces
  • Rapid disintegration and fast dissolution
  • High dilution potential
  • Non-hygroscopic, exceptionally low content of reducing sugars
  • Uniform doses with homogenous distribution

法律資訊

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 1


什麼是Emprove® 套裝?

Emprove® 計劃是一個為我們的篩選器和單次用元件、製藥原料和起始材料提供全面徹底記錄的系統。

Material Qualification Dossier

免費—登入下載

Operational Excellence Dossier

可透過訂閱或付費取得

Operational Excellence Dossier

可透過訂閱或付費取得

了解更多效益 Emprove® 計畫訂閱可提供
為什麼沒有這些文件?
Emprove® 檔案包含旨在支持藥品生產商的註冊過程和風險評估活動的訊息,並包含機密資訊。如果您想存取,請聯絡我們

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

客戶也查看了

Slide 1 of 1

1 of 1

文章

This article describes the advantages of mannitol when used as an excipient in solid drug formulation.

In recent years, mannitol has gained popularity as an excipient in solid dosage formulation due to its beneficial physicochemical properties.

Learn about common tablet manufacturing technologies and the advantages and disadvantages of each.

瞭解常見的片劑製造技術,以及各種技術的優缺點。

查看全部

相關內容

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務